<DOC>
	<DOCNO>NCT00000320</DOCNO>
	<brief_summary>The purpose study compare subject response liquid vs. tablet formulation , assess bioequivalency liquid vs. tablet , compare subject preference , evaluate dose response curve tablet equal liquid form . ''</brief_summary>
	<brief_title>Buprenorphine Formulation Comparison : Sublingual Tablet v . Solution - 1</brief_title>
	<detailed_description>1 ) Compare subject response liquid v tablet formulation 2 ) Assess bioequivalency liquid v tablet 3 ) Compare subject preference 4 ) Evaluate dose response curve tablet = liquid form</detailed_description>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<criteria>M/F age 1865 . Meet DMSIV criterion opiate dependence . Agree condition study sign inform consent . Pregnant nursing woman . Acute medical condition would interfere study participation put safety subject jeopardy . Current daily use anticonvulsant , antabuse neuroleptic . DSMIV diagnosis ETOH sedative/hypnotics dependence .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>opioid dependence</keyword>
</DOC>